[Elucidation of accelerated blood clearance phenomenon caused by repeat injection of PEGylated nanocarriers]
- PMID: 19952519
- DOI: 10.1248/yakushi.129.1445
[Elucidation of accelerated blood clearance phenomenon caused by repeat injection of PEGylated nanocarriers]
Abstract
Liposomes modified with polyethylene glycol (PEG) can stably exist in the bloodstream because the PEG on the liposomes attracts a water shell to the liposomal surface. Since these liposomes are long circulating nanocarriers, they are used as drug and gene delivery tools. Repeat injection of PEGylated liposomes, however, is known to induce the accelerated blood clearance (ABC) phenomenon. In the ABC phenomenon, PEGylated liposomes that are injected subsequent to the first injection are cleared rapidly from the bloodstream and accumulate in the liver, resulting in loss of their long-circulating characteristics. The induction of ABC phenomenon is related to the production of anti-PEG IgM from splenic B cells. To elucidate the mechanism of the phenomenon, we firstly examined the relationship between the induction of ABC phenomenon and the concentration of PEGylated liposomes, and observed that the high dose of those did not induce the phenomenon. Next, we investigated whether polymeric micelles trigger ABC phenomenon or not. Finally, the size-dependency of ABC phenomenon was investigated by use of variously sized PEGylated liposomes and polymeric micelles having PEG chains. Our data suggest that the initiation of ABC phenomenon would be size-dependent, and particles smaller than 30 nm did not induce ABC phenomenon. We anticipate that the elucidation of the ABC phenomenon will be helpful for the development of DDS formulations.
Similar articles
-
Particle size-dependent triggering of accelerated blood clearance phenomenon.Int J Pharm. 2008 Oct 1;362(1-2):197-200. doi: 10.1016/j.ijpharm.2008.06.004. Epub 2008 Jun 7. Int J Pharm. 2008. PMID: 18586076
-
Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micelles.Int J Pharm. 2012 Aug 1;432(1-2):75-9. doi: 10.1016/j.ijpharm.2012.04.049. Epub 2012 Apr 26. Int J Pharm. 2012. PMID: 22562054
-
The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.J Control Release. 2013 Nov 28;172(1):38-47. doi: 10.1016/j.jconrel.2013.07.026. Epub 2013 Aug 7. J Control Release. 2013. PMID: 23933235 Review.
-
[Accelerated blood clearance (ABC) phenomenon induced by administration of PEGylated liposome].Yakugaku Zasshi. 2008 Feb;128(2):233-43. doi: 10.1248/yakushi.128.233. Yakugaku Zasshi. 2008. PMID: 18239370 Review. Japanese.
-
[Recent advances in the study of accelerated blood clearance phenomenon of PEGylated liposomes].Yao Xue Xue Bao. 2010 Jun;45(6):677-83. Yao Xue Xue Bao. 2010. PMID: 20939173 Review. Chinese.
Cited by
-
Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats.Pharmaceutics. 2010 Dec 27;3(1):1-11. doi: 10.3390/pharmaceutics3010001. Pharmaceutics. 2010. PMID: 24310423 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources